There is evidence that urinary interleukin-18 (IL-18) – a proinflammatory cytokine released in response to injury to renal tubular epithelial cells and demonstrated in activated macrophages – might act as an earlier biomarker than serum creatinine in predicting AKI in critically ill adult patients [5-8]. This evidence concerns the gene IL18 and acute kidney injury.